Development of BN Heterocycles for Biomedical Research

用于生物医学研究的氮化硼杂环化合物的开发

基本信息

批准号：
7949958
负责人：
Shih-Yuan Liu
金额：
$ 25.08万
依托单位：
UNIVERSITY OF OREGON
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-09-01 至 2015-07-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): Boron-containing compounds have recently emerged as useful biologically active substances with unique mechanisms of action. This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Specifically, we are interested in 1,2-azaborine heterocycles, which are aromatic compounds isosteric with arenes. The broad utility and fundamental importance of arenes combined with the unique elemental and chemical features of boron make 1,2-azaborines attractive targets for biomedical investigations. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. We outline a synthetic program for the preparation of 1,2-azaborine derivatives, a physical organic program that uses a combined synthetic, structural, spectroscopic, and computational approach to address the aromaticity and reactivity of 1,2-azaborines, and a chemical biology program to establish the reactivity and interactions of BN heterocycles in a biological environment. Our proposed studies will enhance the fundamental understanding of the structure, bonding, and aromaticity the 1,2-azaborine heterocycle and illuminate the changes in the properties of classic aromatic organic molecules (e.g., benzene and indole) upon the replacement of a C=C bond with the isostructural inorganic B-N unit. The basic science resulting from the proposed work will bring new impetus to the chemistry of novel aromatics while at the same time promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles and new mechanistic tools for chemical biology. PUBLIC HEALTH RELEVANCE: This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. The proposed basic research will yield new fundamental knowledge and promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles.

描述（由申请人提供）：含硼化合物最近已成为具有独特作用机制的有用的生物活性物质。该提案描述了一个合成化学计划，旨在开发用于生物医学研究的含硼氮杂环（BN 杂环）。具体来说，我们对 1,2-氮杂硼杂环感兴趣，它是与芳烃等排的芳香族化合物。芳烃的广泛用途和根本重要性与硼独特的元素和化学特征相结合，使 1,2-氮杂硼烷成为生物医学研究的有吸引力的目标。研究硼基药物的潜在好处包括发现传统有机分子无法实现的新型硼特异性生物活性机制，以及减弱目标病原体耐药性的发展。我们概述了制备 1,2-氮杂硼烷衍生物的合成程序、使用组合合成、结构、光谱和计算方法来解决 1,2-氮杂硼烷的芳香性和反应性的物理有机程序，以及化学生物学计划建立生物环境中 BN 杂环的反应性和相互作用。我们提出的研究将增强对1,2-氮杂硼杂环的结构、成键和芳香性的基本理解，并阐明经典芳香族有机分子（例如苯和吲哚）在取代C=C后性质的变化与同构无机 B-N 单元键合。拟议工作所产生的基础科学将为新型芳香族化合物的化学带来新的动力，同时促进新型硼衍生生物活性化合物的设计和开发，这些化合物具有改进的药理学特征和化学生物学的新机制工具。公共健康相关性：该提案描述了一项合成化学计划，旨在开发用于生物医学研究的含硼氮杂环（BN 杂环）。研究硼基药物的潜在好处包括发现传统有机分子无法实现的新型硼特异性生物活性机制，以及减弱目标病原体耐药性的发展。拟议的基础研究将产生新的基础知识，并促进具有改进药理学特征的新型硼衍生生物活性化合物的设计和开发。